CN110521939A - A kind of probiotics fermention food and preparation method thereof adjusting intestinal health - Google Patents
A kind of probiotics fermention food and preparation method thereof adjusting intestinal health Download PDFInfo
- Publication number
- CN110521939A CN110521939A CN201910922333.2A CN201910922333A CN110521939A CN 110521939 A CN110521939 A CN 110521939A CN 201910922333 A CN201910922333 A CN 201910922333A CN 110521939 A CN110521939 A CN 110521939A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- fermentation
- probiotics
- bifidobacterium
- cfu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 65
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 65
- 230000007413 intestinal health Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 235000013305 food Nutrition 0.000 title description 23
- 238000000855 fermentation Methods 0.000 claims abstract description 42
- 230000004151 fermentation Effects 0.000 claims abstract description 42
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 35
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 27
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 27
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims abstract description 27
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 26
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 26
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 26
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 26
- 241000191998 Pediococcus acidilactici Species 0.000 claims abstract description 25
- 241000193749 Bacillus coagulans Species 0.000 claims abstract description 24
- 244000068988 Glycine max Species 0.000 claims abstract description 24
- 229940054340 bacillus coagulans Drugs 0.000 claims abstract description 24
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 23
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 23
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 21
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 21
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000010563 solid-state fermentation Methods 0.000 claims abstract description 19
- 241001465754 Metazoa Species 0.000 claims abstract description 18
- 235000013376 functional food Nutrition 0.000 claims abstract description 18
- 230000011218 segmentation Effects 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 5
- 239000002054 inoculum Substances 0.000 claims description 28
- 239000002609 medium Substances 0.000 claims description 27
- 230000004913 activation Effects 0.000 claims description 21
- 235000012054 meals Nutrition 0.000 claims description 10
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 9
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 9
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 9
- 241000186660 Lactobacillus Species 0.000 claims description 8
- 229940039696 lactobacillus Drugs 0.000 claims description 8
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 230000003519 ventilatory effect Effects 0.000 claims description 3
- 230000036541 health Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 description 50
- 244000005700 microbiome Species 0.000 description 24
- 230000000968 intestinal effect Effects 0.000 description 21
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 235000013325 dietary fiber Nutrition 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 7
- 230000000529 probiotic effect Effects 0.000 description 7
- 230000007420 reactivation Effects 0.000 description 7
- 239000004365 Protease Substances 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 229930187719 Soyasaponin Natural products 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- 241000193468 Clostridium perfringens Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000305071 Enterobacterales Species 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229940083466 soybean lecithin Drugs 0.000 description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108010004032 Bromelains Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- 102000010445 Lactoferrin Human genes 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 201000002313 intestinal cancer Diseases 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 235000021242 lactoferrin Nutrition 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 235000019626 lipase activity Nutrition 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229940092385 radish extract Drugs 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002910 solid waste Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241001116389 Aloe Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000266501 Ormosia ormondii Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000006153 eosin methylene blue Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 230000009605 growth rhythm Effects 0.000 description 1
- 210000004837 gut-associated lymphoid tissue Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- -1 organic acid rare-earth salts Chemical class 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 229940099992 seromycin Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013597 soy food Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/41—Pediococcus
- A23V2400/413—Acidilactici
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention belongs to microbial fermentation application fields, and in particular to a kind of functional food and preparation method thereof by the segmentation solid state fermentation soya bean production of a variety of probiotics.The probiotics fermention functional food provided by the present invention for adjusting intestinal health is will to mix access probiotics after soybean powder with water in proportion to carry out segmentation solid state fermentation and obtain.The probiotics includes lactobacillus reuteri, bifidobacterium longum, Pediococcus acidilactici, lactobacillus plantarum, animal bifidobacteria, lactobacillus paracasei, bifidobacterium adolescentis, bacillus coagulans and bacillus subtilis.By probiotics fermention, increase the benefit active in soybean, and keep it more easily digested, enhance its health-care efficacy to body, the health of body can also be adjusted and be played a significant role.
Description
Technical field:
The invention belongs to microbial fermentation application fields, and in particular to a kind of to be segmented solid state fermentation soya bean by a variety of probiotics
Functional food of production and preparation method thereof.
Background technique:
There are close relationship, the occurrence and development of some diseases are usually associated with intestinal flora for intestinal flora and human health
Variation.In addition, enteron aisle or the maximum immune organ of human body, Intestinal Mucosal Immunity system include gut-associated lymphoid tissue and
Related cell, molecular chaperones, it can resist bacterium, virus and toxin and invade from alimentary canal, be responsible for important immune function,
It is to prevent the intracorporal firm barrier together of extraneous virulence factor invasion.But with current people's the accelerating rhythm of life, diet is practised
The used variation with environment, the environment such as many people live in disease, fatigue, pressure is excessive, abuse of antibiotics, has not enough sleep, drinks
In, so that different degrees of intestinal flora occur unbalance by quite a few crowd, and then influence health.Data show, I
The number of state stomach patient is up to 2.3 hundred million people, wherein there are about 40% patients for a long time by the puzzlement of gastrointestinal disease, PATIENTS WITH LARGE BOWEL
It is in rising trend.In addition, there are different degrees of upset,gastro-intestinals by the resident in China about 70%;Occur per year over 1000000000 person-times
Diarrhea or constipation symptom increase PATIENTS WITH LARGE BOWEL newly up to 400,000.Moreover, intestinal flora is unbalance can also seriously affect exempting from for body
Epidemic disease systematic function, causes immunologic hypofunction, and then causes a variety of diseases, as cirrhosis, gall stone, coronary heart disease, myocardial infarction,
Cerebral arteriovenous malformation etc..It is much for the product of intestinal health problem exploitation currently on the market, it mainly include more traditional
Traditional Chinese and western medicine drug and the probiotic products risen in recent years, but the former often adaptability is low, Special medicine for special disease, and majority has secondary work
With the functional food that cannot function as maintenance intestinal health is taken for a long time, can only take when something goes wrong in enteron aisle, limitation
Greatly.And probiotic products were quickly grown in recent years, probiotics is referred to as microbial food replenishers living, by improving enteron aisle
Microbial balance, to influence host health.Have some patents that intestinal health is adjusted using probiotics at present:
Publication number: the invention of CN106820155A is " for adjusting the lactic bacteria composition of intestinal flora and strengthen immunity
And preparation method thereof " disclose it is a kind of for adjusting the lactic bacteria composition of intestinal flora and strengthen immunity, including lactic acid bacteria
Group synkaryon, the lactic acid bacteria group synkaryon are wrapped with coated layer: the coated layer includes the composition of parts by weight: oligomeric different malt
Sugared 30-50, protein substance 30-50, nitrocellulose 5-10, organic acid rare-earth salts 0.5-1;The lactic acid bacteria group synkaryon is by such as
The bacterial strain of lower parts by weight forms: bifidobacterium lactis 30-40, lactobacillus reuteri 20-30, Lactobacillus rhamnosus 10-20, baby
Bifidobacterium 10-20.
Publication number: a kind of invention " probiotic composition for adjusting intestinal flora health " of CN106820156A discloses one
Kind includes the synthesis probiotic products of lactoferrin, inulin, bromelain, Radish extract, is rich in acidophilus in the product
Lactobacillus, bifidobacterium infantis, bifidobacterium longum, bifidobacterium breve, bifidobacterium bifidum, Lactobacillus rhamnosus, Bulgaria
Add in the beneficial bacteria of intestinal tract such as lactobacillus, lactobacillus plantarum, Lactobacillus casei, lactobacillus paracasei, streptococcus thermophilus and the present invention
The substances such as lactoferrin, inulin and bromelain, Radish extract are entered.
Publication number: the invention " adjusting intestinal flora and the ferment of bowel relaxing functions and preparation method thereof " of CN107125745A is public
A kind of adjusting intestinal flora and the ferment of bowel relaxing functions and preparation method thereof, including following raw material and compound microorganism ferments are opened
It is prepared: fruit 75-82wt%, draft medicinal material 10-14wt% and ingredient 6-10wt%, the addition of the complex microorganism
Amount is the 10-14wt% of the total weight of the raw material;The fruit is the mixture of pineapple, pawpaw, tomato and carrot, described
Draft medicinal material is wheat, oat and the mixture of aloe, and the ingredient is inulin, stachyose, milk ketose, iMOS
With the mixture of oligofructose, the complex microorganism is bifidobacterium bifidum, bifidobacterium longum, bifidobacterium adolescentis, acidophilus
The Mixed Microbes or bifidobacterium bifidum of lactobacillus and streptococcus thermophilus, bifidobacterium longum, bifidobacterium adolescentis, lactobacillus fermenti
With the Mixed Microbes of Lactobacillus helveticus.
The above-mentioned patent that adjusting enteral product is produced using probiotics fermention is mostly prebiotic strains liquid fermentation, and is mostly primary
Fermented product, each growth is horizontal single or uneven, and raw material must be extracted with finished product, concentration, centrifugation and etc., to benefit
The destruction of raw bacterium entirety microenvironment is big, and earlier fermentation and late stage process are complicated and waste material is more, and active ingredient loss is big, product vulnerable to
Pollution, and more auxiliary material is added, product not can guarantee the adaptability and product effect of different crowd.And it is carried out using probiotics
It is segmented solid state fermentation and production process no waste mine, beneficial activity ingredient free of losses, the probiotics of each growth of probiotics horizontal equilibrium
Fermented food and preparation method thereof has not been reported.
Summary of the invention:
The present invention is directed to and mention in view of the shortcomings of the prior art, provide a kind of probiotics fermention food for adjusting intestinal health
For the preparation method of the food, especially for having a digestive problems and enteric flora disturbance, the crowd of hypoimmunity, and
Research Thinking is provided for the production of Related product.
The present invention is segmented solid state fermentation soybean by probiotics to produce a kind of adjusting intestinal flora balance, maintains enteron aisle strong
Health enhances the functional food of immunity of organisms.For soybean substrate, a kind of segmentation process for solid state fermentation has been designed and developed, it will
Different probiotics are accessed in soybean at times by its growth rhythm in soybean ferments, so that each strain quantity in tunning
Balance, metabolite content is abundant, and probiotics quantity is high, and finally obtains one kind and disappear with intestinal flora balance, improvement is adjusted
Change system Tiny ecosystem maintains intestinal health, enhances the probiotics functionality fermented food of immunity of organisms.
To achieve the above object, the present invention adopts the following technical scheme:
A kind of probiotics fermention functional food adjusting intestinal health is will to mix to access with water in proportion after soybean powder
Probiotics carries out segmentation solid state fermentation and obtains.
The probiotics includes lactobacillus reuteri, bifidobacterium longum, Pediococcus acidilactici, lactobacillus plantarum, animal bifid
Bacillus, lactobacillus paracasei, bifidobacterium adolescentis, bacillus coagulans and bacillus subtilis.
The fineness of the soybean powder is preferably to be not less than 100 mesh.
The ratio of the soy meal and water is preferably 1: 1.2-1: 2.0 (mass volume ratios).
The present invention provides the preparation method of the probiotics fermention functional food of above-mentioned adjusting intestinal health, and specific steps are such as
Under:
(1) washing soybean is placed on 60 DEG C of baking ovens to dry 5-6 hours, milling sieves with 100 mesh sieve, and obtains soy meal;
(2) it prepares activation medium: adding 12g soy meal in every 100ml water, obtain activation medium;To activation medium
It sterilizes, condition is 121 DEG C, 20min;
(3) configure fermentation medium: taking soy meal: water=1: 1.2-1: 2.0 (mass volume ratios), mixing are placed on solid
Sterilizing in state fermentor, it is spare that solid-state fermentation culture medium is made;Sterilising conditions are 121 DEG C, 20min;
(4) actication of culture: lactobacillus reuteri, bifidobacterium longum, Pediococcus acidilactici, lactobacillus plantarum, animal bifid bar
Bacterium, lactobacillus paracasei, bifidobacterium adolescentis, bacillus coagulans and bacillus subtilis glycerol tube press 1% (v/v respectively
The volume ratio of activation medium) it is inoculated in activation medium and is activated, pH is naturally, controlled at 37 DEG C;It activates respectively for 24 hours
Afterwards, by 5% (v/v) connect bacterium amount transfer again activation medium carry out re-activation, 37 DEG C reactivation for 24 hours afterwards secondary seed
Liquid;
(5) probiotics stepwise fermentation:
1. in the bacillus subtilis that activation is completed and bacillus coagulans access solid-state fermenter, making every gram of fermentation training
The inoculum concentration for supporting bacillus subtilis in base is 105-106CFU/g, the inoculum concentration of bacillus coagulans are 106-107CFU/g, dimension
37 DEG C of temperature are held, ventilatory capacity 0.1-0.5m3/ min, ferment 10-18h;
2. 1. being walked after fermentation to, activated animal bifidobacteria, Pediococcus acidilactici and lactobacillus plantarum are connect
Enter in solid-state fermenter, makes the inoculum concentration 10 of B. animais in every gram of fermentation medium6-107CFU/g, Pediococcus acidilactici
Inoculum concentration be 106-107CFU/g, the inoculum concentration of lactobacillus plantarum are 105-106CFU/g maintains 37 DEG C of temperature, sealed fermenting
12-24h;
3. 2. being walked after fermentation to, by activated bifidobacterium adolescentis, long Bifidobacterium Bifidum and lactobacillus paracasei
It accesses in solid-state fermenter, makes the inoculum concentration 10 of bifidobacterium adolescentis in every gram of fermentation medium5-106CFU/g, long double qi bars
The inoculum concentration of bacterium is 106-107CFU/g, the inoculum concentration of lactobacillus paracasei are 106-108CFU/g, 37 DEG C of temperature of maintenance are closed
Ferment 18-36h;
4. 3. being walked after fermentation to the, activated lactobacillus reuteri is accessed in solid-state fermenter, makes every gram of hair
The inoculum concentration of lactobacillus reuteri is 10 in ferment culture medium7-108CFU/g maintains 37 DEG C of temperature, sealed fermenting 24-48h;
(6) after fermentation, it is put into vacuum freeze drier and 24-35h is lyophilized, the probiotics for adjusting intestinal health is made
Fermentation Function food;
The soybean is commercially available Non-transgenic soybean;
Preferably, the soybean: water=1: 1.5 (mass volume ratios);
Preferably, after solid state fermentation, vacuum freeze drying 30h is carried out, until water content is not more than 10%;
Preferably, the lactobacillus plantarum be lactobacillus plantarum IOB602 (Lactobacillus plantarum), in
On June 29th, 2018 is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, address: Beijing's southern exposure
No. 3 Institute of Microorganism, Academia Sinica, institute of area North Star West Road 1, postcode 100101, deposit number are CGMCC No.16021;
Preferably, the animal bifidobacteria is animal bifidobacteria IOB402 (Bifidobacterium
Animalis), it is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center on June 29th, 2018,
Address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Institute of Microorganism, Academia Sinica, postcode 100101, deposit number are
CGMCC No.16028;
Preferably, the lactobacillus paracasei is lactobacillus paracasei IOB413 (Lactobacillus paracasei),
It is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center on June 29th, 2018, address: Beijing
The institute 3 of Chaoyang District North Star West Road 1, Institute of Microorganism, Academia Sinica, postcode 100101, deposit number CGMCC
No.16022;
Preferably, the bifidobacterium adolescentis is bifidobacterium adolescentis IOB506
(Bifidobacteriumadolescentis), Chinese microorganism strain preservation management committee is preserved on June 29th, 2018
Member's meeting common micro-organisms center, address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, Institute of Microorganism, Academia Sinica,
Postcode 100101, deposit number are CGMCC No.16026;
Preferably, the bacillus coagulans be bacillus coagulans IOB502 (Bacillus coagulans), in
On June 29th, 2018 is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, address are as follows: court, Beijing
The institute 3 of positive area's North Star West Road 1, Institute of Microorganism, Academia Sinica, postcode 100101, deposit number are as follows: CGMCC
No.16025;
Preferably, the bacillus subtilis be bacillus subtilis IOB430 (Bacillus subtilis), in
On June 29th, 2018 is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, address are as follows: court, Beijing
The institute 3 of positive area's North Star West Road 1, Institute of Microorganism, Academia Sinica, postcode 100101, deposit number CGMCC
No.16024;
Preferably, the lactobacillus reuteri is lactobacillus reuteri IOB423 (Lactobacillus reuteri),
China Committee for Culture Collection of Microorganisms's common micro-organisms center, address are preserved on June 29th, 2018 are as follows: Beijing
The institute 3 of Chaoyang District North Star West Road 1, Institute of Microorganism, Academia Sinica, postcode 100101, deposit number CGMCC
No.16023;
Preferably, the bifidobacterium longum be bifidobacterium longum IOB515 (Bifidobacterium longum), in
On June 29th, 2018 is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, address are as follows: court, Beijing
The institute 3 of positive area's North Star West Road 1, Institute of Microorganism, Academia Sinica, postcode 100101, deposit number CGMCC
No.16027;
Preferably, the Pediococcus acidilactici is Pediococcus acidilactici IOB701 (Pediococcus acidilactici),
China Committee for Culture Collection of Microorganisms's common micro-organisms center, address are preserved on July 10th, 2018 are as follows: Beijing
The institute 3 of Chaoyang District North Star West Road 1, Institute of Microorganism, Academia Sinica, postcode 100101, deposit number CGMCC
No.16077。
The utility model has the advantages that
Probiotics is a kind of by improving intestine microenvironment to the microorganism to host's generation beneficial effect.It can
Inhibit growth of pathogenic bacteria by participating in intestinal microecology balance, maintains intestinal health.A large number of studies show that probiotics can be adjusted
It saves body gastrointestinal tract normal flora, keep microecological balance, improve food digestion rate and biological value, reduce serum cholesterol, control
Endotoxin processed inhibits the growth and breeding of spoilage organisms and the generation of spoilage product in enteron aisle, manufactures nutriment, stimulation group hair-weaving
It educates, to send out the nutritional status of body, physiological function, cell infection, drug effect, toxic reaction, immune response, tumour
The generations effect such as raw, aging course and unexpected emergency reaction.
For soybean originating from China, China is that soy food product is original earliest, spreads country at most, just there is human consumption soybean very early
Tradition of fermented product, including fermented soya bean, fermented bean drink, yellow bean sauce and various fermented bean curd etc. are all with soybean or bean product inoculation mould hair
Made of after ferment.The nutritive value of soybean is very high, referred to as " king in beans ", " meat of Tanaka ", " green cow's milk " etc., is several
The food most praised highly by nutritionist in hundred kinds of natural foods.Soybean protein rich in, isoflavones, plant are solid
Alcohol, soyabean oligosaccharides etc. can enhance immunity of organism, prevent vascular sclerosis, have the effects that hypoglycemic, anti-oxidant, furthermore soybean
It is also rich in dietary fiber, and dietary fiber is very important to promoting good digestion and excretion solid waste to play the role of.It grinds
Study carefully and show appropriately supplementary fibre element, the food increase in enteron aisle can be made to soften, promote intestines peristalsis, to accelerate defecation speed
Degree prevents constipation and reduces the risk of intestinal cancer.Meanwhile dietary fiber has apparent reduction plasma cholesterol, adjusts stomach and intestine function
The functions such as energy and insulin level.
The probiotics fermention functional food provided by the invention for adjusting intestinal health, had both saved the nutriture value of natural plants
Value, but the nutrition health-care functions with probiotics fermention product, effect are obvious;The probiotics fermention can adjust intestinal health
Food by be segmented solid state fermentation be prepared, by probiotics fermention, increase the benefit active in soybean, and make
It is more easily digested, enhances its health-care efficacy to body.The probiotic food of this patent, which removes, has intestinal health
Have outside splendid health-care effect, the health of body can also be adjusted and be played a significant role.
Specific embodiment:
The technical solution of the present invention will be described in detail below with reference to the embodiments and experimental examples, specific embodiment described herein
Be only used to explain the present invention, but the present invention is not limited to following specific embodiments and protection scope it is without being limited thereto.
The percentage sign " % " being related in embodiment refers to mass percent if not specified, and the percentage of solution refers to
Containing the grams of solute in 100mL, percentage between liquid refers to the volume ratio of the solution at 25 DEG C.
Bacterial strain employed in following embodiment is lactobacillus plantarum IOB602 (Lactobacillus plantarum),
Deposit number is CGMCC No.16021;Animal bifidobacteria IOB402 (Bifidobacterium animalis), preservation are compiled
Number be CGMCC No.16028;Lactobacillus paracasei IOB413 (Lactobacillus paracasei), deposit number is
CGMCC No.16022;Bifidobacterium adolescentis IOB506 (Bifidobacteriumadolescentis), deposit number are
CGMCC No.16026;Bacillus coagulans IOB502 (Bacillus coagulans), deposit number are as follows: CGMCC
No.16025;Bacillus subtilis IOB430 (Bacillus subtilis), deposit number are CGMCC No.16024;Roy
Family name's lactobacillus IOB423 (Lactobacillus reuteri), deposit number are CGMCC No.16023;Bifidobacterium longum
IOB515 (Bifidobacterium longum), deposit number are CGMCC No.16027;Pediococcus acidilactici IOB701
(Pediococcus acidilactici), deposit number are CGMCC No.16077.
Actication of culture mode used by following embodiment is as follows if not otherwise specified:
(1) it prepares activation medium: adding 12g soy meal in every 100ml water, obtain activation medium;To activation medium
It sterilizes, condition is 121 DEG C, 20min;
(2) actication of culture: lactobacillus reuteri, bifidobacterium longum, Pediococcus acidilactici, lactobacillus plantarum, animal bifid bar
Bacterium, lactobacillus paracasei, bifidobacterium adolescentis, bacillus coagulans and bacillus subtilis glycerol tube press 1% (v/v respectively
With the volume ratio of activation medium) it is inoculated in activation medium and is activated, pH is naturally, controlled at 37 DEG C;It activates respectively
After for 24 hours, by the bacterium amount that connects of 5% (v/v), switching activation medium carries out re-activation respectively again, and 37 DEG C of reactivations obtain afterwards for 24 hours
Secondary seed solution.
The present invention will be explained by specific embodiment below.
Embodiment 1: the probiotics fermention preparation method of functional food of intestinal health is adjusted
1, the determination of probiotics inoculum concentration
(1) washing soybean is placed on 60 DEG C of baking ovens to dry 5-6 hours, milling sieves with 100 mesh sieve, and obtains soy meal;
(2) it prepares activation medium: adding 12g soy meal in every 100ml water, obtain activation medium;To activation medium
It sterilizes, condition is 121 DEG C, 20min;
(3) configure fermentation medium: taking soy meal: water=1: 1.4 (mass volume ratios), mixing are placed on 6T solid state fermentation
Sterilizing in tank, it is spare that solid-state fermentation culture medium is made;6T solid-state fermenter sterilising conditions are 121 DEG C, 20min;
(4) actication of culture: lactobacillus reuteri, bifidobacterium longum, Pediococcus acidilactici, lactobacillus plantarum, animal bifid bar
Bacterium, lactobacillus paracasei, bifidobacterium adolescentis, bacillus coagulans and bacillus subtilis glycerol tube press 1% (v/v respectively
The volume ratio of activation medium) it is inoculated in activation medium and is activated, pH is naturally, controlled at 37 DEG C;It activates respectively for 24 hours
Afterwards, by 5% (volume ratio of v/v re-activation culture medium) connect bacterium amount transfer again activation medium carry out re-activation, 37
DEG C reactivation for 24 hours afterwards secondary seed solution;
(5) probiotics fermention:
1. the bacillus subtilis that activation is completed and bacillus coagulans access 6T solid-state fermenter by inoculation pipeline
In, 37 DEG C of temperature are maintained, ventilatory capacity 0.1m3/ min, ferment 10h;
2. 1. being walked after fermentation to, activated animal bifidobacteria, Pediococcus acidilactici and lactobacillus plantarum are led to
It crosses in inoculation pipeline access 6T solid-state fermenter, maintains 37 DEG C of temperature, sealed fermenting 12h;
3. 2. being walked after fermentation to, by activated bifidobacterium adolescentis, long Bifidobacterium Bifidum and lactobacillus paracasei
It is accessed in 6T solid-state fermenter by inoculation pipeline, maintains 37 DEG C of temperature, sealed fermenting 18h;
4. 3. walking after fermentation to the, activated lactobacillus reuteri is accessed into 6T solid state fermentation by inoculation pipeline
In tank, 37 DEG C of temperature are maintained, sealed fermenting is for 24 hours;
(6) each strain inoculum concentration is respectively connected in following ratio, after fermentation, respectively to the probiotics in fermented sample
Viable count is detected, as a result such as table 1:
Strain label: No. 1 is lactobacillus plantarum single bacterium, and No. 2 are animal bifidobacteria single bacterium, and No. 3 are lactobacillus paracasei
Single bacterium, No. 4 are bifidobacterium adolescentis single bacterium, and No. 5 are bacillus coagulans single bacterium, and No. 6 are lactobacillus reuteri single bacterium, and No. 7 are
Bifidobacterium longum single bacterium, No. 8 are Pediococcus acidilactici single bacterium, and No. 9 are bacillus subtilis single bacterium;
Inoculum concentration: the inoculum concentration of bacillus subtilis is fixed as 5 × 105CFU/g, bacillus subtilis, condensation gemma
Bacillus, bifidobacterium longum, Pediococcus acidilactici, lactobacillus plantarum, animal bifidobacteria, lactobacillus paracasei, bifidobacterium adolescentis,
Lactobacillus reuteri accesses in solid-state fermentation substrate in proportion in batches, bacillus subtilis, bacillus coagulans, animal bifid
Bacillus, Pediococcus acidilactici, lactobacillus plantarum, bifidobacterium adolescentis, bifidobacterium longum, lactobacillus paracasei, lactobacillus reuteri
The ratio between inoculum concentration are as follows:
Group unification: 1: 10: 10: 10: 1: 1: 10: 50: 100;
Combination two: 1: 5: 5: 10: 1: 1: 10: 100: 100;
Combination three: 1: 10: 5: 10: 1: 1: 10: 50: 100;
Combination four: 1: 5: 10: 5: 1: 1: 10: 50: 100;
Combination five: 1: 10: 5: 10: 1: 1: 10: 100: 100;
Combination six: 1: 5: 10: 10: 1: 1: 5: 50: 100;
Combination seven: 1: 10: 5: 20: 1: 1: 10: 50: 100;
Combination eight: 1: 10: 10: 10: 1: 1: 10: 100: 100;
Combination nine: 1: 10: 10: 5: 1: 1: 10: 100: 100.
Number of live bacteria of probiotics (CFU/g) after each strain different vaccination amount solid state fermentation of table 1
Group unification | Combination two | Combination three | Combination four | Combination five | Combination six | Combination seven | Combination eight | Combination nine | |
No. 1 | 2.77×109 | 9.02×108 | 4.23×108 | 6.65×108 | 5.12×109 | 3.45×108 | 5.34×108 | 4.82×109 | 7.56×108 |
No. 2 | 4.55×109 | 3.75×109 | 7.84×107 | 8.76×107 | 7.67×109 | 2.94×109 | 6.56×108 | 4.67×109 | 3.13×108 |
No. 3 | 6.99×109 | 1.02×108 | 9.87×107 | 4.76×108 | 7.32×108 | 5.34×108 | 4.01×108 | 3.17×109 | 2.19×109 |
No. 4 | 1.63×107 | 8.27×107 | 5.75×108 | 7.88×108 | 9.65×108 | 6.32×108 | 3.69×108 | 8.16×108 | 3.65×108 |
No. 5 | 2.01×107 | 4.25×107 | 5.26×107 | 7.48×107 | 5.05×109 | 5.25×108 | 4.15×108 | 3.19×109 | 1.86×108 |
No. 6 | 3.98×108 | 8.01×108 | 9.66×107 | 3.26×107 | 5.74×107 | 7.93×107 | 3.16×107 | 4.27×109 | 3.79×107 |
No. 7 | 1.05×109 | 1.43×108 | 2.34×108 | 4.32×108 | 3.28×109 | 5.12×108 | 2.17×109 | 5.32×109 | 6.32×108 |
No. 8 | 2.28×107 | 4.68×107 | 7.47×107 | 1.78×108 | 8.36×107 | 9.78×107 | 6.68×107 | 7.34×108 | 8.43×107 |
No. 9 | 3.43×109 | 1.57×107 | 6.19×107 | 2.18×108 | 7.27×107 | 8.12×107 | 5.15×107 | 6.45×108 | 7.46×107 |
Total viable count | 2.17×1010 | 6.25×109 | 8.06×108 | 2.67×109 | 2.01×1010 | 7.85×109 | 8.13×109 | 4.04×1010 | 3.31×109 |
The ratio between optimal inoculum concentration obtained as shown in Table 1 is combination eight: 1: 10: 10: 10: 1: 1: 10: 100: 100, at this time
Total viable count is 4.04 × 1010CFU/mL。
2, the determination of material-water ratio
The ratio (mass volume ratio) of soy meal in solid-state fermentation culture medium and water is made into 1:1.2,1:1.4,1 respectively:
1.6,1:1.8, the inoculum concentration of bacillus subtilis is 5 × 105CFU/g, bacillus subtilis, bacillus coagulans, animal are double
Discrimination bacillus, Pediococcus acidilactici, lactobacillus plantarum, bifidobacterium adolescentis, bifidobacterium longum, lactobacillus paracasei, Luo Yishi cream bar
The ratio between bacterium inoculum concentration is 1: 10: 10: 10: 1: 1: 10: 100: 100 inoculations, remaining step is fermented with embodiment 1-1, is fermented
After, the number of live bacteria of probiotics in fermented sample is detected respectively, as a result such as table 2:
Viable count (CFU/g) after the fermentation substrate fermentation of the different material-water ratios of table 2
Ratio | 1:1.2 | 1:1.4 | 1:1.6 | 1:1.8 |
Lactobacillus plantarum single bacterium | 1.87×109 | 2.71×109 | 3.25×109 | 1.51×109 |
B. animais single bacterium | 3.28×109 | 4.37×109 | 2.85×109 | 1.13×109 |
Lactobacillus paracasei single bacterium | 4.39×108 | 5.11×108 | 3.28×108 | 2.58×108 |
Bifidobacterium adolescentis single bacterium | 5.69×108 | 6.27×108 | 9.24×108 | 3.42×108 |
Bacillus coagulans single bacterium | 1.24×109 | 3.15×109 | 3.76×109 | 1.50×109 |
Lactobacillus reuteri single bacterium | 3.98×109 | 7.29×109 | 7.77×109 | 4.54×109 |
Long Bifidobacterium Bifidum single bacterium | 5.78×108 | 7.47×108 | 6.32×108 | 7.21×108 |
Pediococcus acidilactici single bacterium | 4.23×109 | 6.32×109 | 8.38×109 | 6.54×109 |
Bacillus subtilis single bacterium | 2.97×109 | 3.26×109 | 4.19×109 | 3.12×109 |
Total viable count | 2.61×1010 | 3.98×1010 | 4.53×1010 | 1.39×1010 |
The results are shown in Table 2: best material-water ratio is 1:1.6, that is, is measured total in gained probiotics fermention functional food
Viable count is 4.53 × 1010CFU/g。
3, the determination of fermentation time
Each phases-time of probiotics fermention is identified as following groups:
Group 1:10h, 12h, 18h, for 24 hours;
Group 2:18h, for 24 hours, 36h, 48h;
Group 3:15h, 18h, for 24 hours, 36h;
Group 4:12h, 18h, for 24 hours, for 24 hours;
Group 5:18h, 18h, 36h, 36h.
The inoculum concentration of bacillus subtilis is 5 × 105CFU/g, bacillus subtilis, bacillus coagulans, animal bifid
Bacillus, Pediococcus acidilactici, lactobacillus plantarum, bifidobacterium adolescentis, bifidobacterium longum, lactobacillus paracasei, lactobacillus reuteri
The ratio between inoculum concentration is 1: 10: 10: 10: 1: 1: 10: 100: 100 inoculations, material-water ratio 1:1.6, remaining condition with embodiment 1-1,
Count plate is carried out after fermentation, as a result such as table 3:
Viable count (CFU/g) when 3 different fermentations of table after indirect fermentation
Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | |
Lactobacillus plantarum single bacterium | 3.12×109 | 5.19×109 | 3.77×109 | 3.94×109 | 3.81×109 |
B. animais single bacterium | 3.01×109 | 4.29×109 | 2.21×109 | 1.36×109 | 8.15×108 |
Lactobacillus paracasei single bacterium | 2.78×108 | 2.37×108 | 6.71×108 | 3.45×108 | 1.37×108 |
Bifidobacterium adolescentis single bacterium | 7.03×108 | 6.47×108 | 5.17×108 | 5.49×108 | 5.42×108 |
Bacillus coagulans single bacterium | 2.12×109 | 2.69×109 | 2.57×108 | 6.01×108 | 2.57×109 |
Lactobacillus reuteri single bacterium | 6.25×109 | 6.51×109 | 3.92×108 | 7.41×108 | 3.98×109 |
Long Bifidobacterium Bifidum single bacterium | 5.53×108 | 6.02×108 | 5.31×108 | 4.71×108 | 2.37×108 |
Pediococcus acidilactici single bacterium | 7.55×109 | 7.17×109 | 6.88×109 | 2.54×109 | 5.78×109 |
Bacillus subtilis single bacterium | 4.01×109 | 3.67×109 | 2.69×109 | 2.85×109 | 2.88×109 |
Total viable count | 4.37×1010 | 4.86×1010 | 1.75×1010 | 2.54×1010 | 2.89×1010 |
The results are shown in Table 3: each stage Best Times of probiotics fermention combination two, be respectively as follows: 18h, for 24 hours, 36h,
48h, measuring total viable count in probiotics fermention functional food at this time is 4.86 × 1010CFU/g。
4, fermentation front and back culture medium active constituent variation
By above-mentioned optimum inoculation amount, best material-water ratio, best fermentation time, remaining is consolidated referring to embodiment 1-1 step
State fermentation, compares before carrying out composition detection, with fermentation after fermentation.Utilize Syrups by HPLC gossypose, wood
Sugared content;Utilize forint phenol reaction assay polypeptide and polyphenol content;Using GB5009.88-2014, " national food safety standard is eaten
The measurement of dietary fiber in product " in method measurement dietary fiber content;With reference to article " the colorimetric method survey of Song Hongzhe, Zhao Yong etc.
Determine the parsing of soyasaponin " measurement soyasaponin content;With reference to article " the spectrophotometry measurement of Liu Pengli, Zhang Shuanling etc.
Phosphatidylcholine content in soybean lecithin " measuring method measurement soybean lecithin content;With reference to the article of Zheng Bin, Wang Shu etc.
Method in " protein and protease content measurement in blueberry ferment " measures protease content;It is surveyed using the quick colorimetric of amylase
Method is determined to measure the vigor of amylase;With reference in GBT22492-2008 " National Standard of the People's Republic of China's soy peptide powder "
Method measures content of peptides;It is surveyed with reference to the method in noble, Han Si equality article " comparison of lipase activity detection method "
Determine lipase activity;Utilize side in GB5009235-2016 " measurement of amino-acid nitrogen in national food safety standard food "
Method one measures amino-acid state.
The culture medium active constituent variation of the fermentation of table 4 front and back
As shown in Table 4, after probiotics fermention, polyphenol, stachyose, gossypose, dietary fiber in solid-state fermentation substrate,
Soyasaponin, soybean lecithin, protease, amylase, lipase, antibacterial peptide, amino-acid nitrogen content be significantly increased.
Polyphenol can interact in human body with enteric microorganism, influence intestinal flora and then being degraded by enteric microorganism, change
Kind intestinal microflora, increases the quantity of lactobacillus and Bifidobacterium, further influences human health;Dietary fiber is good to promoting
Good digestion and excretion solid waste plays the role of very important.Studies have shown that appropriately supplementary fibre is plain, can make in enteron aisle
Food increase soften, promote intestines peristalsis, to accelerate defecation speed, prevent constipation and reduce the risk of intestinal cancer;Study table
Bright, soyasaponin has the function of adjusting immune;Protease, lipase, amylase can effectively promote as digestive ferment to disappear
Change, reduce digestive system burden, promotes digestive system health;" food " of the stachyose as probiotics, in human gastrointestinal tract
The profitable strains such as Bifidobacterium, Bacillus acidi lactici have extremely apparent proliferation function, environment in human body alimentary canal can be improved rapidly,
Adjust Tiny ecosystem colony balance;Gossypose can promote simultaneously the flourish of the beneficial bacteriums such as Bifidobacterium, Bacillus acidi lactici, and have
Effect inhibits the breeding of harmful intestinal tract bacteria, establishes the intestinal flora environment of health, in addition, gossypose belongs to water-soluble dietary fiber,
Equivalent efficacy with dietary fiber;Polypeptide can directly be absorbed by intestinal cell, mitigate the burden of enteron aisle, in addition, polypeptide is also
The beneficial bacteriums such as Bacillus acidi lactici, the Bifidobacterium in enteron aisle can be promoted to grow, promote enterogastric peristalsis and food absorption, to gastritis etc.
Disease of digestive system has good preventive and therapeutic effect;Amino-acid nitrogen can react probiotics to the fermentation journey of substrate indirectly
Degree, also proportional with the content of amino acid, amino acid nitrogen content increases, and illustrates the part macromolecular substances quilt in substrate
It decomposes for small-molecule substance, it is easier to which absorption of human body reduces the burden to digestive system.
5, it is lyophilized
It by the fermentation medium of optimal fermentation condition output, is put into vacuum freeze drier and 30h is lyophilized, be made and adjust intestines
The probiotics fermention functional food of road health.
Embodiment 2: improve the experimental study experimental method of intestinal microflora:
1, the preparation of the probiotics fermention food of intestinal health is adjusted: after preparing probiotics fermention food by embodiment 1-4
30h is lyophilized in vacuum freeze drier.
2, experimental animal: taking male, and weight 18-22g is separated from milk kunming mice 90 of one month, solves purchased from Chinese people
Fang Jun The Fourth Military Medical University Experimental Animal Center.
3, experiment reagent: Bifidobacterium selective medium (BBL), Bifidobacterium selective culture medium (Lbs), Yihong methylene blue
Agar, Sodium azide-crystal violet-aesculin agar, tryptone-sulphite-seromycin agar basis (TSC), D-Cycloserine
Solution, physiological saline.
4, experimental procedure: being divided into blank group, experimental group 1, experimental group 2 for 90 mouse, aseptic collection each group before testing
Stool in mice carries out count plate with 10 times of gradient dilutions respectively.Blank group is every with 0.10mL/10g mouse weight sterile saline
2 stomach-fillings of day, continuous 14d;Common probiotic food 10g in the market is added 20mL sterile distilled water to dilute by experimental group 1, with
The weight dilution stomach-filling 2 times a day of 0.10mL/10g mouse, continuous 14d;Experimental group 2 adds probiotic food 10g produced by the invention
20mL sterile distilled water dilution, with the weight dilution stomach-filling 2 times a day of 0.10mL/10g mouse, continuous 14d;Last time gavages for 24 hours
Aseptic collection each group stool in mice afterwards carries out count plate.Bifidobacterium is detected with BBL agar, detects newborn bar with Lbs agar
Bacterium, detects enterobacteria with eosin methylene blue agar, detects enterococcus with Sodium azide-crystal violet-aesculin agar, is examined with TSC agar
Survey C.perfringens.
5, mouse general state is observed: diet situation, the mobility, hair of mouse each group are observed being since first time stomach-filling
Color, stool situation etc..
Experiment conclusion:
1, the general status of mouse: administration front and back, mouse is active active, sensitiveer to the reacting condition of ambient enviroment,
And appetite is good.
2, Bifidobacterium, lactobacillus, enterobacteria, enterococcus, C.perfringens quantity in the mouse intestinal of administration front and back
It influences, is shown in Table 5.
The administration front and back mouse intestinal flora quantity of table 5 (CFU/g)
Found out by table 5 is available, after experimental group 1 and experimental group 2 gavage, beneficial bacterium Bifidobacterium in mouse intestinal and
Lactobacillus increased significantly, and harmful bacteria enterobacteria, enterococcus and C.perfringens significantly reduce, but from Microflora
From the point of view of comparison, the effect of experimental group 2 will be substantially better than experimental group 1, this illustrates the common probiotics on this product and current market
Product is compared, and the effect for adjusting intestinal flora is more preferable.And control group gavage before with gavage rear each Microflora without significant changes,
This illustrates that the probiotics functional food of invention can effectively improve probiotics quantity in enteron aisle, inhibits harmful bacteria proliferation,
Adjust intestinal flora balance.
Embodiment 3: clinical therapeutic efficacy
Clinical examination is used for after 30h being lyophilized in probiotics fermention food vaccum freezing dryer obtained in embodiment 1-4
It tests, 20 patients of each case, men and women is fifty-fifty, takes orally seven, twice a day, each 5g, therapeutic effect is shown in Table 6.
Therapeutic effect of the 6 this patent product of table to different enteric disorders
Illness | It cures | It is effective | Effectively | In vain |
Diarrhea | 20 | 0 | 0 | 0 |
Constipation | 20 | 0 | 0 | 0 |
Colitis | 18 | 2 | 0 | 0 |
From the point of view of clinical trial effect, the probiotics fermention food of invention has a variety of intestines problems excellent
Therapeutic effect plays the effect of bidirectional modulation to diarrhea and constipation.
The foregoing is only a preferred embodiment of the present invention, but scope of protection of the present invention is not limited thereto,
It should be pointed out that anyone skilled in the art is in the technical scope disclosed by the present invention, skill according to the present invention
Art scheme and its inventive concept are subject to equivalent substitution or change, should be covered by the protection scope of the present invention, and therefore, this is specially
The scope of protection shall be subject to the appended claims for benefit.
Claims (4)
1. it is a kind of adjust intestinal health probiotics fermention functional food, which is characterized in that be by after soybean powder in proportion with
Water mixes access probiotics and carries out segmentation solid state fermentation and obtain, and the segmentation solid state fermentation is specific as follows:
1. making withered in every gram of fermentation medium in the bacillus subtilis that activation is completed and bacillus coagulans access culture medium
The inoculum concentration of careless bacillus is 105-106CFU/g, the inoculum concentration of bacillus coagulans are 106-107CFU/g maintains temperature 37
DEG C, ventilatory capacity 0.1-0.5m3/ min, ferment 10-18h;
2. 1. being walked after fermentation to the, activated animal bifidobacteria, Pediococcus acidilactici and lactobacillus plantarum are accessed, made
The inoculum concentration of B. animais is 10 in every gram of fermentation medium6-107CFU/g, the inoculum concentration of Pediococcus acidilactici are 106-
107CFU/g, the inoculum concentration of lactobacillus plantarum are 105-106CFU/g maintains 37 DEG C of temperature, sealed fermenting 12-24h;
3. 2. being walked after fermentation to the, activated bifidobacterium adolescentis, long Bifidobacterium Bifidum and lactobacillus paracasei are accessed,
Make the inoculum concentration 10 of bifidobacterium adolescentis in every gram of fermentation medium5-106CFU/g, the inoculum concentration of long Bifidobacterium Bifidum are 106-
107CFU/g, the inoculum concentration of lactobacillus paracasei are 106-108CFU/g maintains 37 DEG C of temperature, sealed fermenting 18-36h;
4. 3. being walked after fermentation to, activated lactobacillus reuteri is accessed, Luo Yishi in every gram of fermentation medium is made
The inoculum concentration of lactobacillus is 107-108CFU/g maintains 37 DEG C of temperature, sealed fermenting 24-48h.
2. a kind of probiotics fermention functional food for adjusting intestinal health as described in claim 1, which is characterized in that soy meal
Mass volume ratio with water is 1: 1.2-1: 2.0.
3. a kind of probiotics fermention functional food for adjusting intestinal health as described in claim 1, which is characterized in that fermentation knot
Shu Hou is put into vacuum freeze drier and 24-35h is lyophilized, and the probiotics fermention functional food for adjusting intestinal health is made.
4. a kind of probiotics fermention functional food for adjusting intestinal health as described in claim 1, which is characterized in that
The lactobacillus plantarum is lactobacillus plantarum (Lactobacillus plantarum) IOB602, deposit number CGMCC
No.16021;
The animal bifidobacteria is animal bifidobacteria (Bifidobacterium animalis) IOB402, and deposit number is
CGMCC No.16028;
The lactobacillus paracasei is lactobacillus paracasei (Lactobacillus paracasei) IOB413, and deposit number is
CGMCC No.16022;
The bifidobacterium adolescentis is bifidobacterium adolescentis (Bifidobacteriumadolescentis) IOB506, and preservation is compiled
Number be CGMCC No.16026;
The bacillus coagulans are bacillus coagulans (Bacillus coagulans) IOB502, deposit number are as follows: CGMCC
No.16025;
The bacillus subtilis is bacillus subtilis (Bacillus subtilis) IOB430, deposit number CGMCC
No.16024;
The lactobacillus reuteri is lactobacillus reuteri (Lactobacillus reuteri) IOB423, and deposit number is
CGMCC No.16023;
The bifidobacterium longum is bifidobacterium longum (Bifidobacterium longum) IOB515, deposit number CGMCC
No.16027;
The Pediococcus acidilactici is Pediococcus acidilactici (Pediococcus acidilactici) IOB701, and deposit number is
CGMCC No.16077。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910922333.2A CN110521939A (en) | 2019-09-26 | 2019-09-26 | A kind of probiotics fermention food and preparation method thereof adjusting intestinal health |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910922333.2A CN110521939A (en) | 2019-09-26 | 2019-09-26 | A kind of probiotics fermention food and preparation method thereof adjusting intestinal health |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110521939A true CN110521939A (en) | 2019-12-03 |
Family
ID=68670480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910922333.2A Pending CN110521939A (en) | 2019-09-26 | 2019-09-26 | A kind of probiotics fermention food and preparation method thereof adjusting intestinal health |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110521939A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111011839A (en) * | 2019-12-11 | 2020-04-17 | 天津创源生物技术有限公司 | Ecological food for simulating excrement transplantation and preparation method and application thereof |
CN111685310A (en) * | 2020-06-04 | 2020-09-22 | 包选平 | Composite edible fungus enzyme and preparation method thereof |
CN111955719A (en) * | 2020-07-06 | 2020-11-20 | 齐鲁工业大学 | Special medical food for treating inflammatory bowel disease and preparation method thereof |
CN112980737A (en) * | 2021-04-01 | 2021-06-18 | 江南大学 | Bifidobacterium adolescentis for promoting proliferation of animal bifidobacterium and application thereof |
CN113080461A (en) * | 2021-05-14 | 2021-07-09 | 艾兰得生物科技研究泰州有限公司 | Probiotics with function of inhibiting growth of proteus mirabilis as well as fermentation liquor and application thereof |
CN114774307A (en) * | 2022-03-30 | 2022-07-22 | 深圳龙宫伊莱特生物科技有限公司 | Composite probiotic, fermented feed and preparation method thereof |
CN115517367A (en) * | 2022-11-28 | 2022-12-27 | 广东益可维生物技术有限公司 | Application of lactobacillus paracasei SMN-LBK in preparation of product for promoting intestinal health |
CN116333910A (en) * | 2022-09-23 | 2023-06-27 | 华中农业大学 | Culture medium and method for promoting lactobacillus reuteri growth |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106472704A (en) * | 2016-09-27 | 2017-03-08 | 天津科技大学 | Bean milk fermenting and producing probiotic bacteria functional drinkss and food and preparation method thereof |
CN109805232A (en) * | 2019-03-01 | 2019-05-28 | 天津科技大学 | Jujube three-stage probiotics fermention produces Low acid micro-ecological foods |
-
2019
- 2019-09-26 CN CN201910922333.2A patent/CN110521939A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106472704A (en) * | 2016-09-27 | 2017-03-08 | 天津科技大学 | Bean milk fermenting and producing probiotic bacteria functional drinkss and food and preparation method thereof |
CN109805232A (en) * | 2019-03-01 | 2019-05-28 | 天津科技大学 | Jujube three-stage probiotics fermention produces Low acid micro-ecological foods |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111011839A (en) * | 2019-12-11 | 2020-04-17 | 天津创源生物技术有限公司 | Ecological food for simulating excrement transplantation and preparation method and application thereof |
CN111685310A (en) * | 2020-06-04 | 2020-09-22 | 包选平 | Composite edible fungus enzyme and preparation method thereof |
CN111955719A (en) * | 2020-07-06 | 2020-11-20 | 齐鲁工业大学 | Special medical food for treating inflammatory bowel disease and preparation method thereof |
CN112980737A (en) * | 2021-04-01 | 2021-06-18 | 江南大学 | Bifidobacterium adolescentis for promoting proliferation of animal bifidobacterium and application thereof |
CN113080461A (en) * | 2021-05-14 | 2021-07-09 | 艾兰得生物科技研究泰州有限公司 | Probiotics with function of inhibiting growth of proteus mirabilis as well as fermentation liquor and application thereof |
CN114774307A (en) * | 2022-03-30 | 2022-07-22 | 深圳龙宫伊莱特生物科技有限公司 | Composite probiotic, fermented feed and preparation method thereof |
CN114774307B (en) * | 2022-03-30 | 2023-07-25 | 深圳龙宫伊莱特生物科技有限公司 | Composite probiotics, fermented feed and preparation method thereof |
CN116333910A (en) * | 2022-09-23 | 2023-06-27 | 华中农业大学 | Culture medium and method for promoting lactobacillus reuteri growth |
CN115517367A (en) * | 2022-11-28 | 2022-12-27 | 广东益可维生物技术有限公司 | Application of lactobacillus paracasei SMN-LBK in preparation of product for promoting intestinal health |
CN115517367B (en) * | 2022-11-28 | 2023-05-05 | 广东益可维生物技术有限公司 | Application of lactobacillus paracasei SMN-LBK in preparation of intestinal health promoting product |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110521939A (en) | A kind of probiotics fermention food and preparation method thereof adjusting intestinal health | |
CN106834187B (en) | Bifidobacterium bifidum and application thereof | |
CN100489086C (en) | Lactic acid bacteria capable of stimulating mucosal immunity | |
CN103893214B (en) | Probiotics viable bacteria powder produced by whole oat solid-state mixed fermentation and preparation method of probiotics viable bacteria powder | |
CN101897729B (en) | Probiotic composition and preparation thereof | |
CN109123295A (en) | A kind of probiotics solid beverage and preparation method thereof | |
CN108783462A (en) | A kind of industrial process of beneficial bacteria of intestinal tract preparation | |
CN102018216A (en) | Composition containing bifidobacteria for adjusting intestinal flora and enhancing immunity | |
CN106420847B (en) | Composition for assisting in protecting gastric mucosa and/or relieving gastrectasia and microecological preparation thereof | |
CN1273838A (en) | Nutritive composition containing symbiotic fermentation culture medium of dead probiotics | |
TWI739495B (en) | Composition for promoting defecation and use therefor | |
CN108823129A (en) | A kind of cultural method of probiotics | |
EP4053262A1 (en) | Lactobacillus casei producing short-chain fatty acids, cultivation method therefor and application thereof | |
CN105754876B (en) | Highland barley rice koji, highland barley rice koji product and preparation method thereof | |
CN110521785A (en) | Probiotics fermention functional food and its preparation | |
CN108770974A (en) | A kind of antianaphylactic probiotic gel candy and preparation method thereof | |
CN102021162A (en) | High-activity bifidobacterium powder and preparation method thereof | |
CN108782758A (en) | A kind of fermented type synbiotic goat milk powder and preparation method thereof | |
CN116555076B (en) | Bifidobacterium longum subspecies longum MY1 and application thereof in preparation of food and medicine for relaxing bowels and protecting intestines | |
CN111254088A (en) | Bacillus coagulans strain and application thereof | |
CN110122567A (en) | Composite fermentation cream with anti-oxidation function and preparation method thereof | |
TW202313959A (en) | Process for promoting growth of probiotics | |
CN102524794B (en) | Preparation method of serum cholesterol reduction Kluyveromyces marxianus freeze-dried powder | |
CN105802876B (en) | A kind of composite probiotics ferment clover tender shoots powder preparation and its preparation method and application | |
CN110463892A (en) | A kind of lactic acid bacteria solid beverage and preparation method thereof improving human body intestinal canal health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191203 |